Premium
Robotic Whipple for pancreatic ductal and ampullary adenocarcinoma: 10 years experience of a US single‐center
Author(s) -
Valle Valentina,
Fernandes Eduardo,
Mangano Alberto,
Aguiluz Gabriela,
Bustos Roberto,
Bianco Francesco,
Giulianotti Pier Cristoforo
Publication year - 2020
Publication title -
the international journal of medical robotics and computer assisted surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.556
H-Index - 53
eISSN - 1478-596X
pISSN - 1478-5951
DOI - 10.1002/rcs.2135
Subject(s) - pancreaticoduodenectomy , pancreatic ductal adenocarcinoma , medicine , pancreatic carcinoma , single center , retrospective cohort study , adenocarcinoma , whipple procedure , ductal carcinoma , pancreatic cancer , general surgery , surgery , pancreas , cancer , breast cancer
BACKGROUND There is currently ample consensus about the safety and feasibility of robotic pancreaticoduodenectomy (RPD). However, few studies are available on the long‐term oncological outcomes of this procedure. We present a long‐term survival analysis (up to 10 years) of our series of RPD carried out for ductal and ampullary adenocarcinoma. METHODS A retrospective analysis of a prospectively collected approved database was carried out including 39 patients who underwent RPD for pancreatic ductal and ampullary adenocarcinomas. RESULTS The 5‐year overall survival for ductal and ampullary carcinoma was 41% with an estimated median and mean survival of 27 and 52 months. The ampullary group had significantly longer 5‐year survival (68%) than the ductal group (30%). CONCLUSION Our data show, within the limitations of their retrospective nature, that robotic pancreaticoduodenectomy provides similar short‐ and long‐term survival outcomes compared to open technique in the treatment of pancreatic ductal and ampullary adenocarcinoma.